Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Sonoma Pharmaceuticals (SNOA) Assets Average (2016 - 2025)

Sonoma Pharmaceuticals has reported Assets Average over the past 15 years, most recently at $13.7 million for Q4 2025.

  • For Q4 2025, Assets Average changed 0.46% year-over-year to $13.7 million; the TTM value through Dec 2025 reached $13.7 million, changed 0.46%, while the annual FY2025 figure was $14.2 million, 8.19% down from the prior year.
  • Assets Average for Q4 2025 was $13.7 million at Sonoma Pharmaceuticals, down from $14.2 million in the prior quarter.
  • Over five years, Assets Average peaked at $19.6 million in Q4 2021 and troughed at $13.7 million in Q4 2024.
  • A 5-year average of $15.4 million and a median of $14.6 million in 2021 define the central range for Assets Average.
  • On a YoY basis, Assets Average climbed as much as 23.69% in 2022 and fell as far as 26.25% in 2022.
  • Year by year, Assets Average stood at $19.6 million in 2021, then fell by 26.25% to $14.4 million in 2022, then fell by 2.2% to $14.1 million in 2023, then dropped by 3.19% to $13.7 million in 2024, then rose by 0.46% to $13.7 million in 2025.
  • Business Quant data shows Assets Average for SNOA at $13.7 million in Q4 2025, $14.2 million in Q3 2025, and $14.1 million in Q2 2025.